Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer. (Q47951269)

7 February 2018

title

Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer. (English)

1 reference

7 February 2018

1 reference

Sunahara M

1

1 reference

7 February 2018

Shishikura T

2

1 reference

7 February 2018

Takahashi M

3

1 reference

7 February 2018

Todo S

4

1 reference

7 February 2018

Yamamoto N

5

1 reference

7 February 2018

Kimura H

6

1 reference

7 February 2018

Kato S

7

1 reference

7 February 2018

Ishioka C

8

1 reference

7 February 2018

Ikawa S

9

1 reference

7 February 2018

Ikawa Y

10

1 reference

7 February 2018

Nakagawara A

11

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

7 February 2018

published in

Oncogene

1 reference

7 February 2018

volume

18

1 reference

7 February 2018

page(s)

3761-3765

1 reference

7 February 2018

issue

25

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202972

exact match

0 references

cites work

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

7 January 2021

p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

7 January 2021

Screening patients for heterozygous p53 mutations using a functional assay in yeast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

7 January 2021

The general rules for clinical and pathological recording of breast cancer. Japanese Breast Cancer Society

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

7 January 2021

Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202972

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202972

1 reference

7 February 2018

PubMed ID

10391684

1 reference

7 February 2018